AQR Arbitrage’s Deep Medicine Acquisition Corp. Rights DMAQR Stock Holding History

AQR Arbitrage’s Portfolio DMAQR Stock Details DMAQR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-369,302	Closed	-$111K	–	723
2023 Q4	$111K	Hold	369,302	–	–	﹤0.01%	380
2023 Q3	$111K	Hold	369,302	–	–	0.01%	415
2023 Q2	$59.1K	Sell	369,302 -409	-0.1%	-$67	﹤0.01%	520
2023 Q1	$51.8K	Sell	369,711 -5,289	-1%	-$536	﹤0.01%	617
2022 Q4	$18.8K	Hold	375,000	–	–	﹤0.01%	845
2022 Q3	$14K	Hold	375,000	–	–	﹤0.01%	1075
2022 Q2	$41K	Hold	375,000	–	–	﹤0.01%	939
2022 Q1	$67K	Hold	375,000	–	–	﹤0.01%	855
2021 Q4	$120K	Buy	+375,000	New	+$119K	﹤0.01%	1186

AQR Arbitrage's DMAQR Position: Q1 2024 in Review

AQR Arbitrage sold out of Deep Medicine Acquisition Corp. Rights (DMAQR) in Q1 2024, closing a stake of 369,302 shares — an estimated $111K sold.

AQR Arbitrage first reported a position in DMAQR in Q4 2021 and held it in 9 quarters. The position peaked at $120K in Q4 2021. 0 funds tracked by Wall St. Rank hold DMAQR as of Q1 2024.

AQR Arbitrage reported no remaining Deep Medicine Acquisition Corp. Rights position as of Q1 2024 after selling out during the quarter.
AQR Arbitrage sold 369,302 Deep Medicine Acquisition Corp. Rights shares in Q1 2024, an estimated $111K.
AQR Arbitrage first reported a position in Deep Medicine Acquisition Corp. Rights in Q4 2021 and held it in 9 quarters.
AQR Arbitrage's Deep Medicine Acquisition Corp. Rights position peaked at $120K in Q4 2021.
0 funds tracked by Wall St. Rank held Deep Medicine Acquisition Corp. Rights as of Q1 2024.

Based on AQR Arbitrage's 13F filing for Q1 2024, filed 15 May 2024.